Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Killed but metabolically active Pseudomonas aeruginosa-based vaccine induces protective humoral- and cell-mediated immunity against Pseudomonas aeruginosa pulmonary infections.

Meynet E, Laurin D, Lenormand JL, Camara B, Toussaint B, Le Gouëllec A.

Vaccine. 2018 Mar 27;36(14):1893-1900. doi: 10.1016/j.vaccine.2018.02.040. Epub 2018 Mar 2.

PMID:
29506924
2.

Functional Characterization of Cell-Free Expressed OprF Porin from Pseudomonas aeruginosa Stably Incorporated in Tethered Lipid Bilayers.

Maccarini M, Gayet L, Alcaraz JP, Liguori L, Stidder B, Watkins EB, Lenormand JL, Martin DK.

Langmuir. 2017 Sep 26;33(38):9988-9996. doi: 10.1021/acs.langmuir.7b01731. Epub 2017 Sep 12.

PMID:
28845995
3.

Targeted release of transcription factors for human cell reprogramming by ZEBRA cell-penetrating peptide.

Caulier B, Berthoin L, Coradin H, Garban F, Dagher MC, Polack B, Toussaint B, Lenormand JL, Laurin D.

Int J Pharm. 2017 Aug 30;529(1-2):65-74. doi: 10.1016/j.ijpharm.2017.06.073. Epub 2017 Jun 21.

PMID:
28647433
4.

Coupling neutron reflectivity with cell-free protein synthesis to probe membrane protein structure in supported bilayers.

Soranzo T, Martin DK, Lenormand JL, Watkins EB.

Sci Rep. 2017 Jun 13;7(1):3399. doi: 10.1038/s41598-017-03472-8.

5.

Therapeutic effects of proteoliposomes on X-linked chronic granulomatous disease: proof of concept using macrophages differentiated from patient-specific induced pluripotent stem cells.

Brault J, Vaganay G, Le Roy A, Lenormand JL, Cortes S, Stasia MJ.

Int J Nanomedicine. 2017 Mar 20;12:2161-2177. doi: 10.2147/IJN.S128611. eCollection 2017.

6.

Functional characterization of p7 viroporin from hepatitis C virus produced in a cell-free expression system.

Soranzo T, Cortès S, Gilde F, Kreir M, Picart C, Lenormand JL.

Protein Expr Purif. 2016 Feb;118:83-91. doi: 10.1016/j.pep.2015.10.004. Epub 2015 Oct 22.

7.

Cell-free production of VDAC directly into liposomes for integration with biomimetic membrane systems.

Liguori L, Stidder B, Alcaraz JP, Lenormand JL, Cinquin P, Martin DK.

Prep Biochem Biotechnol. 2016 Aug 17;46(6):546-51. doi: 10.1080/10826068.2015.1068800.

PMID:
26443900
8.

Anti-Tumor Effects of Bak-Proteoliposomes against Glioblastoma.

Liguori L, Pastorino F, Rousset X, Alfano S, Cortes S, Emionite L, Daga A, Ponzoni M, Lenormand JL.

Molecules. 2015 Sep 1;20(9):15893-909. doi: 10.3390/molecules200915893.

9.

[Biomimetic sensors in biomedical research].

Gayet L, Lenormand JL.

Med Sci (Paris). 2015 Jun-Jul;31(6-7):654-9. doi: 10.1051/medsci/20153106019. Epub 2015 Jul 7. Review. French.

10.

MD11-mediated delivery of recombinant eIF3f induces melanoma and colorectal carcinoma cell death.

Marchione R, Laurin D, Liguori L, Leibovitch MP, Leibovitch SA, Lenormand JL.

Mol Ther Methods Clin Dev. 2015 Feb 4;2:14056. doi: 10.1038/mtm.2014.56. eCollection 2015.

11.

[Pulmonary alveolar proteinosis].

Jouneau S, Kerjouan M, Briens E, Lenormand JP, Meunier C, Letheulle J, Chiforeanu D, Lainé-Caroff C, Desrues B, Delaval P.

Rev Mal Respir. 2014 Dec;31(10):975-91. doi: 10.1016/j.rmr.2014.08.009. Epub 2014 Oct 18. Review. French.

12.

ZEBRA cell-penetrating peptide as an efficient delivery system in Candida albicans.

Marchione R, Daydé D, Lenormand JL, Cornet M.

Biotechnol J. 2014 Aug;9(8):1088-94. doi: 10.1002/biot.201300505. Epub 2014 Feb 12.

PMID:
24449606
13.

The translational factor eIF3f: the ambivalent eIF3 subunit.

Marchione R, Leibovitch SA, Lenormand JL.

Cell Mol Life Sci. 2013 Oct;70(19):3603-16. doi: 10.1007/s00018-013-1263-y. Epub 2013 Jan 25. Review.

14.

Functional characterisation of the WW minimal domain for delivering therapeutic proteins by adenovirus dodecahedron.

Villegas-Méndez A, Fender P, Garin MI, Rothe R, Liguori L, Marques B, Lenormand JL.

PLoS One. 2012;7(9):e45416. doi: 10.1371/journal.pone.0045416. Epub 2012 Sep 27.

15.

Recombinant Nox4 cytosolic domain produced by a cell or cell-free base systems exhibits constitutive diaphorase activity.

Nguyen MV, Zhang L, Lhomme S, Mouz N, Lenormand JL, Lardy B, Morel F.

Biochem Biophys Res Commun. 2012 Mar 16;419(3):453-8. doi: 10.1016/j.bbrc.2012.01.136. Epub 2012 Feb 3.

PMID:
22326263
16.

Crystallization of the membrane protein hVDAC1 produced in cell-free system.

Deniaud A, Liguori L, Blesneac I, Lenormand JL, Pebay-Peyroula E.

Biochim Biophys Acta. 2010 Aug;1798(8):1540-6. doi: 10.1016/j.bbamem.2010.04.010. Epub 2010 May 9.

17.

Characterization of the cell-penetrating properties of the Epstein-Barr virus ZEBRA trans-activator.

Rothe R, Liguori L, Villegas-Mendez A, Marques B, Grunwald D, Drouet E, Lenormand JL.

J Biol Chem. 2010 Jun 25;285(26):20224-33. doi: 10.1074/jbc.M110.101550. Epub 2010 Apr 9.

18.

In vivo delivery of antigens by adenovirus dodecahedron induces cellular and humoral immune responses to elicit antitumor immunity.

Villegas-Mendez A, Garin MI, Pineda-Molina E, Veratti E, Bueren JA, Fender P, Lenormand JL.

Mol Ther. 2010 May;18(5):1046-53. doi: 10.1038/mt.2010.16. Epub 2010 Feb 23.

19.

A simple method for the reconstitution of membrane proteins into giant unilamellar vesicles.

Varnier A, Kermarrec F, Blesneac I, Moreau C, Liguori L, Lenormand JL, Picollet-D'hahan N.

J Membr Biol. 2010 Feb;233(1-3):85-92. doi: 10.1007/s00232-010-9227-8. Epub 2010 Feb 5.

PMID:
20135103
20.

Production of recombinant proteoliposomes for therapeutic uses.

Liguori L, Lenormand JL.

Methods Enzymol. 2009;465:209-23. doi: 10.1016/S0076-6879(09)65011-4.

PMID:
19913169
21.

Single-step production of functional OEP24 proteoliposomes.

Liguori L, Blesneac I, Madern D, Vivaudou M, Lenormand JL.

Protein Expr Purif. 2010 Jan;69(1):106-11. doi: 10.1016/j.pep.2009.07.004. Epub 2009 Jul 12.

PMID:
19602439
22.

A bacterial cell-free expression system to produce membrane proteins and proteoliposomes: from cDNA to functional assay.

Liguori L, Marques B, Lenormand JL.

Curr Protoc Protein Sci. 2008 Nov;Chapter 5:Unit 5.22. doi: 10.1002/0471140864.ps0522s54.

PMID:
19016436
23.

Expression and purification of ZEBRA fusion proteins and applications for the delivery of macromolecules into mammalian cells.

Rothe R, Lenormand JL.

Curr Protoc Protein Sci. 2008 Nov;Chapter 18:Unit 18.11. doi: 10.1002/0471140864.ps1811s54.

PMID:
19016434
24.

Liposomes-mediated delivery of pro-apoptotic therapeutic membrane proteins.

Liguori L, Marques B, Villegas-Mendez A, Rothe R, Lenormand JL.

J Control Release. 2008 Mar 20;126(3):217-27. doi: 10.1016/j.jconrel.2007.12.004. Epub 2007 Dec 14.

PMID:
18234390
25.

Liposome-mediated cellular delivery of active gp91(phox).

Marques B, Liguori L, Paclet MH, Villegas-Mendéz A, Rothe R, Morel F, Lenormand JL.

PLoS One. 2007 Sep 12;2(9):e856.

26.

New insights into the membrane topology of the phagocyte NADPH oxidase: characterization of an anti-gp91-phox conformational monoclonal antibody.

Campion Y, Paclet MH, Jesaitis AJ, Marques B, Grichine A, Berthier S, Lenormand JL, Lardy B, Stasia MJ, Morel F.

Biochimie. 2007 Sep;89(9):1145-58. Epub 2007 Feb 20.

PMID:
17397983
27.

Production of membrane proteins using cell-free expression systems.

Liguori L, Marques B, Villegas-Méndez A, Rothe R, Lenormand JL.

Expert Rev Proteomics. 2007 Feb;4(1):79-90. Review.

PMID:
17288517
28.

High level production of secreted proteins: example of the human tissue inhibitor of metalloproteinases 1.

Crombez L, Marques B, Lenormand JL, Mouz N, Polack B, Trocme C, Toussaint B.

Biochem Biophys Res Commun. 2005 Nov 25;337(3):908-15. Epub 2005 Sep 30.

PMID:
16219294
29.

Human Spy1 promotes survival of mammalian cells following DNA damage.

Barnes EA, Porter LA, Lenormand JL, Dellinger RW, Donoghue DJ.

Cancer Res. 2003 Jul 1;63(13):3701-7.

30.

Human Speedy: a novel cell cycle regulator that enhances proliferation through activation of Cdk2.

Porter LA, Dellinger RW, Tynan JA, Barnes EA, Kong M, Lenormand JL, Donoghue DJ.

J Cell Biol. 2002 Apr 29;157(3):357-66. Epub 2002 Apr 29.

31.

MyoD binds to Mos and inhibits the Mos/MAP kinase pathway.

Solhonne B, Lenormand JL, Pelpel K, Leibovitch MP, Leibovitch SA.

FEBS Lett. 1999 Nov 12;461(1-2):107-10.

32.

Speedy: a novel cell cycle regulator of the G2/M transition.

Lenormand JL, Dellinger RW, Knudsen KE, Subramani S, Donoghue DJ.

EMBO J. 1999 Apr 1;18(7):1869-77.

33.

Mos activates myogenic differentiation by promoting heterodimerization of MyoD and E12 proteins.

Lenormand JL, Benayoun B, Guillier M, Vandromme M, Leibovitch MP, Leibovitch SA.

Mol Cell Biol. 1997 Feb;17(2):584-93.

34.

Identification of a novel regulatory element in the c-mos locus that activates transcription in somatic cells.

Lenormand JL, Leibovitch SA.

Biochem Biophys Res Commun. 1995 May 5;210(1):181-8.

PMID:
7741739
35.

Myogenin binds to and represses c-fos promoter.

Trouche D, Masutani H, Groisman R, Robin P, Lenormand JL, Harel-Bellan A.

FEBS Lett. 1995 Mar 20;361(2-3):140-4.

36.

p34cdc2 protein is complexed with the c-mos protein in rat skeletal muscle.

Leibovitch SA, Guillier M, Lenormand JL, Leibovitch MP.

Oncogene. 1993 Sep;8(9):2361-9.

PMID:
8395677
37.

Repression of c-fos promoter by MyoD on muscle cell differentiation.

Trouche D, Grigoriev M, Lenormand JL, Robin P, Leibovitch SA, Sassone-Corsi P, Harel-Bellan A.

Nature. 1993 May 6;363(6424):79-82.

PMID:
8386804
38.

Identification of a cis acting element responsible for muscle specific expression of the c-mos protooncogene.

Lenormand JL, Guillier M, Leibovitch SA.

Nucleic Acids Res. 1993 Feb 11;21(3):695-702.

39.

Accumulation of the c-mos protein is correlated with post-natal development of skeletal muscle.

Leibovitch SA, Guillier M, Lenormand JL, Leibovitch MP.

Oncogene. 1991 Sep;6(9):1617-22.

PMID:
1833718
40.

Rat myogenic c-mos cDNA: cloning sequence analysis and regulation during muscle development.

Leibovitch SA, Lenormand JL, Leibovitch MP, Guiller M, Mallard L, Harel J.

Oncogene. 1990 Aug;5(8):1149-57.

PMID:
1697408
41.

[Coronary surgery after the age of 70 years. Profile of the population and results].

Rioux C, Vidal V, Leguerrier A, Le Couls H, Lenormand JP, Boulvard J, Logeais Y.

Ann Chir. 1988;42(8):529-33. Review. French. No abstract available.

PMID:
3063194
42.

[Chest wall infections after surgery with extracorporeal circulation. Reflections on the therapeutic modalities (curative and preventive), apropos of 4,835 consecutive operations].

Leguerrier A, Fasquel JL, Rosat P, Guillou L, Scordia P, Lenormand JP, Le Couls H, Rioux C, Logeais Y.

Ann Chir. 1986 Nov;40(8):540-7. French. No abstract available.

PMID:
3566147
43.

[Prevention of mediastinitis after cardiac surgery].

Leguerrier A, Logeais Y, Rioux C, Fasquel JL, Lenormand JP, Le Couls H, Rosat P, Guillou L, Scordia P.

Cah Anesthesiol. 1985 Dec;33(8):667-73. French. No abstract available.

PMID:
3836732
44.

Twofold critical geometry for lasers.

Floch AL, Lenormand JM, Ropars G, Naour RL.

Opt Lett. 1984 Nov 1;9(11):496-8.

PMID:
19721645
45.

[Idiopathic retroperitoneal fibrosis in an HLA B27 antigen carrier].

Thorel JB, Toulet R, Lenormand JP, Schmitt B.

Rev Rhum Mal Osteoartic. 1982 Dec;49(12):891-5. French. No abstract available.

PMID:
6984539
46.

Spatial-asymmetry distribution of a saturated-absorption peak.

Floch AL, Lenormand JM, Jézéquel G, Le Naour R.

Opt Lett. 1981 Jan 1;6(1):48-50.

PMID:
19701322
47.

[Serum IgE in infants. Usual values and values in intolerance to cow's milk proteins (author's transl)].

Basuyau JP, Mallet E, Lenormand JJ, Brunelle P, de Ménibus CH.

Nouv Presse Med. 1980 Feb 23;9(9):591-4. French.

PMID:
7360660
48.

[Severe anemia revealaing Horton's disease].

Massari R, Leonetti P, Lenormand JP, Douguet JC.

Nouv Presse Med. 1979 Jan 6;8(1):44. French. No abstract available.

PMID:
554061

Supplemental Content

Loading ...
Support Center